Share this:
November 25th, 2013

Mayo Clinic first in U.S. to test stem cell use in clinical trial for pediatric congenital heart disease

By Center for Regenerative Medicine

Mayo Clinic recently announced the first stem cell-based clinical trial for congenital heart disease. The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood can help children with Hypoplastic Left Heart Syndrome, a rare defect where the left side of the heart is critically underdeveloped.

Read the full news release and watch a video describing the research:

Tags: HLHS, Mayo Clinic, research, stem cells, Timothy Nelson, Uncategorized

Comment

Please login or register to post a comment.
Contact Us · Privacy Policy